Neoduplamox Bambini (Aroma Frutti Misti) (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Neoduplamox Bambini (Aroma Frutti Misti), is a penicillin beta‑lactamase inhibitor combination presented as an oral suspension for pediatric use. It treats bacterial infections such as otitis media, sinusitis, pneumonia, urinary tract and skin infections in children.

GNH USA supplies Neoduplamox Bambini (Aroma Frutti Misti) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics and timely delivery to meet patient needs.

Neoduplamox Bambini (amoxicillin/clavulanic acid) is used to treat bacterial infections of the respiratory, urinary and skin systems. - Acute otitis media: reduces bacterial load, relieving ear pain and inflammation. - Sinusitis: eradicates causative pathogens and improves sinus drainage. - Community‑acquired pneumonia: combats the infecting organisms and supports recovery of lung function. - Urinary tract infections: eliminates uropathogens and alleviates urinary symptoms. - Skin and soft tissue infections: clears bacterial involvement and promotes healing of affected skin.

Adverse reactions to Neoduplamox Bambini may vary in frequency and severity.

Common Side Effects: - Diarrhea: loose stools that may be mild to moderate. - Nausea: feeling of stomach discomfort or urge to vomit. - Rash: mild skin redness or itching. - Vomiting: expulsion of stomach contents. - Abdominal pain: cramping or discomfort in the stomach area.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty and swelling. - Clostridioides difficile‑associated diarrhea: severe colitis presenting with watery stools. - Liver enzyme elevation: increased ALT or AST indicating hepatic stress. - Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement. - Neutropenia: marked reduction in white blood cells increasing infection risk.

Before prescribing Neoduplamox Bambini, consider the following precautions. - Assess allergy history: avoid in patients with known penicillin or clavulanic acid hypersensitivity. - Monitor renal function: dose adjustment may be required in impaired kidney function. - Evaluate hepatic status: use caution in patients with liver disease. - Observe for superinfection: prolonged use can lead to fungal or bacterial overgrowth. - Use with caution in the elderly: increased risk of adverse reactions. - Store at room temperature: keep in the original container, protect from moisture and heat.

Neoduplamox Bambini can interact with several medicines; categorize them as follows.

Major Interactions (Avoid): - Probenecid: may increase amoxicillin plasma concentrations, raising toxicity risk. - Methotrexate: can reduce clearance, leading to enhanced methotrexate toxicity. - Warcoma: may potentiate anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: antibiotic may reduce efficacy, consider additional contraception. - Allopurinol: combined use may increase risk of skin rash. - Ciprofloxacin: concurrent use may heighten seizure risk in susceptible individuals.